Skip to main content

b 212 500 (Niacin Extended-Release 500 mg)

Pill with imprint b 212 500 is White, Capsule-shape and has been identified as Niacin Extended-Release 500 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 212 500

Niacin Extended-Release

Imprint
b 212 500
Strength
500 mg
Color
White
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
Inactive Ingredients
povidone k90, stearic acid

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7392 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0584 (Discontinued) AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.